Dextromethorphan and guaifenesin use ought to be monitored diligently in sufferers with "very poor metabolizer" CYP2D6 enzyme ranges and patients who're sedated. This mixture medication has a huge median poisonous dose (TD50) to median successful dose (ED50) ratio (or therapeutic index) in these patients. To overview: Scientific investigations Based on https://cryptoscamrecoverycompany45669.liberty-blog.com/30257947/dextromethorphan-dxm-for-sale-an-overview